Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Novogene to acquire Pacific Biosciences' Sequel Systems

Jan. 17, 2017

Horizon Discovery broadens gene-editing capabilities

Jan. 17, 2017

UCB reports progress from genetics collaborations with leading universities

Jan. 16, 2017

Ono gains access to Ligand Pharmaceuticals' OmniAb platform

Dec. 27, 2016

Ab Initio Biotherapeutics and Pfizer enter GPCR collaboration

Dec. 14, 2016

MedImmune and Abpro to collaborate in developing bispecific antibody

Dec. 1, 2016

CRISPR/Cas9 gene editing advances, first patient receives cells with edited genes

Nov. 23, 2016

AbbVie discontinues development program under Halozyme collaboration

Nov. 22, 2016

PharmAkea extends collaboration with Celgene

Nov. 21, 2016

MRC Technology, UCB and University of Leicester form research consortium

Nov. 9, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...